Loading...
Sorafenib-triggered radiation recall dermatitis with a disseminated exanthematous reaction
Sorafenib is a multi-targeted kinase inhibitor, which is the current standard treatment for advanced hepatocellular carcinoma (HCC). Only one case of radiation recall dermatitis (RRD) associated with sorafenib has been reported so far. Our patient with recurrent HCC was treated with palliative radio...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Korean Society for Radiation Oncology
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3797277/ https://ncbi.nlm.nih.gov/pubmed/24137563 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3857/roj.2013.31.3.171 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|